INDICATION: QUZYTTIR is indicated for the treatment of acute urticaria in adults and children 6 months of age and older. Limitations of Use: QUZYTTIR is not recommended in pediatric patients <6 years of age with impaired renal or hepatic function.

How to dose and administer QUZYTTIR

Actor portrayal of a female nurse in scrubs with a stethoscope around her neck writing on a clipboard Actor portrayal of a female nurse in scrubs with a stethoscope around her neck writing on a clipboard Actor portrayal.

Dosing and administration1

Vial of QUZYTTIR
  • QUZYTTIR is a single-use injectable product for intravenous administration only.
  • QUZYTTIR is preservative-free and does not require refrigeration or reconstitution.
  • The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria.
  • Administer QUZYTTIR as an intravenous push over a period of 1 to 2 minutes.
  • QUZYTTIR is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.
Graphic droplets indicating 2.5 mg for children 6 mos to 1 yr, 5 mg for ages 6-11, 10 mg for 12 years and older
  • If using QUZYTTIR as an antihistamine prior to infusion product administration,
  • refer to the infusion product prescribing information for instructions.

Storage and handling1

QUZYTTIR (cetirizine hydrochloride injection) should be stored at 20°C to 25°C (68° to 77°F), excursions permitted to 15° – 30°C (59° – 86°F). 

Discard unused portion.

Icon of a handshake
Request a representative

Get more information about QUZYTTIR and resources available to support your patients.

×